Adam Vogel
Stock Analyst at Craig-Hallum
(4.66)
# 834
Out of 4,994 analysts
32
Total ratings
81.2%
Success rate
40.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Reiterated: Buy | $36 | $25.75 | +39.81% | 9 | Aug 12, 2026 | |
| LBRX LB Pharmaceuticals | Reiterated: Buy | $36 → $45 | $42.69 | +5.41% | 5 | Aug 12, 2026 | |
| ATHE Alterity Therapeutics | Initiated Coverage: Buy | $12 | $3.78 | +217.46% | 1 | Aug 11, 2026 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | $10 | $5.72 | +74.83% | 6 | Aug 6, 2026 | |
| PEPG PepGen | Reiterated: Buy | $11 | $2.98 | +269.13% | 2 | Aug 6, 2026 | |
| DSGN Design Therapeutics | Reiterated: Buy | $22 | $13.16 | +67.17% | 5 | Aug 4, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $40 → $25 | $10.86 | +130.20% | 3 | Jul 28, 2026 | |
| HIT Health In Tech | Reiterated: Buy | n/a | $0.8466 | - | 1 | Apr 10, 2026 |
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $36
Current: $25.75
Upside: +39.81%
LB Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $36 → $45
Current: $42.69
Upside: +5.41%
Alterity Therapeutics
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.78
Upside: +217.46%
Aclaris Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $5.72
Upside: +74.83%
PepGen
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $2.98
Upside: +269.13%
Design Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $22
Current: $13.16
Upside: +67.17%
MapLight Therapeutics
Jul 28, 2026
Reiterated: Buy
Price Target: $40 → $25
Current: $10.86
Upside: +130.20%
Health In Tech
Apr 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.8466
Upside: -